Professional Documents
Culture Documents
Medical Ward
Medical Ward
Medical Ward
BSN 4B GROUP 2
DRUG STUDY
NAME OF DRUG DOSAGE,
INDICATION/ NURSING
(GENERIC & ROUTE, CONTRAINDICATION ADVERSE EFFECT
ACTION RESPONSIBILITY
BRAND NAME) FREQUENCY
Generic Name: 750 mg TIV q6 Active against Body Whole: Patient & Family
gram-positive Similar to those for Education
Ampicillin Sodium microorganisms such penicillin G. Note: Ampicillin rash is
as alpha- and Hypersensitivity believed to be
Brand Name: beta-Hemolytic (pruritus, urticaria, nonallergenic and
Ampicin, streptococci, eosinophilia, therefore its appearance
Omnipen-N, Diplococcus hemolytic anemia, is not an absolute
Penbritin, pneumoniae, interstitial nephritis, contraindication to future
Polycillin-N, non-penicillinase anaphylactoid therapy.
SK-Ampicillin-N, producing reaction);
Staphylococci, and superinfections. Report diarrhea to
Totacillin-N Listeria. Major CNS:Convulsive physician; do not
advantage over seizures with high self-medicate. Give a
penicillin G is doses. detailed report to the
Classifications: physician regarding
enhanced action GI:Diarrhea, nausea,
Anti-infective; against most strains of vomiting, onset, duration, character
antibiotic; Enterococci and pseudomembranous of stools, associated
aminopenicillin several gram-negative colitis. symptoms, temperature
strains including other:Severe pain and weight loss (if any)
Escherichia coli, (following IM); to help rule out the
Pregnancy possibility of
Neisseria gonorrhoeae, phlebitis (following
Category: B drug-induced, potentially
N. meningitidis, IV);
Haemophilus Skin:Rash. fatal pseudomembranous
influenzae, Proteus colitis .
mirabilis, Salmonella Report S&S of
(including typhosa), superinfection (onset of
and Shigella. Inactive black, hairy tongue; oral
against Mycoplasma, lesions or soreness; rectal
rickettsiae, fungi, and or vaginal itching;
viruses. vaginal discharge; loose,
foul-smelling stools; or
unusual odor to urine).
Notify physician if no
improvement is noted
within a few days after
therapy is started.
Do not breast feed while
taking this drug without
consulting physician
LI, CHRISTELLE JEAN G.
BSN 4B GROUP 2
DRUG STUDY
NAME OF DRUG DOSAGE,
INDICATION/ NURSING
(GENERIC & ROUTE, CONTRAINDICATION ADVERSE EFFECT
ACTION RESPONSIBILITY
BRAND NAME) FREQUENCY
Generic Name: 250 mg TIV q8 Suppresses protein Hypersensitivity Diarrhea Use parenteral form for
Clindamycin synthesis by anaerobic infections
hydrochloride microorganisms by Pseudomembranous
binding to ribosomes colitis
Use in treating minor
Brand Name: Prevents peptide bacterial infections Tinnitis Reduce dosage in severe
Dalacin-C, Cleocin formation renal impairment
Nausea and vomiting
Does not diffuse Use in clients with a Slin rashes
Classification: adequately to the CSF history of regional Give parenteral dosage
Antibiotic, enteritis, ulcerative Dry skin for hospitalized clients
lincosamide colitis, meningitis, Burning only
antibiotic-associated
colitis Itching
Skin erythema Administer IV over
20-60 minutes
Use for treating viral Peeling
infections Assess for diarrhea and
Oily skin possible colitis
Lactation Cardiopulmonary
arrest
Assess extent of
Anaphylaxis infections and if
Agranulocytosis improvement occurs
Aplastic anemia
Monitor liver and renal
function
Urogenital: urinary
retention/ frequency,
menopausal
symptoms